Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients

被引:51
作者
Cheng, SH
Horng, CF
Clarke, JL
Tsou, MH
Tsai, SY
Chen, CM
Jian, JJ
Liu, MC
West, M
Huang, AT
Prosnitz, LR
机构
[1] Koo Fdn Sun Yat Sen Canc Ctr, Dept Radiat Oncol, Taipei, Taiwan
[2] Koo Fdn Sun Yat Sen Canc Ctr, Res Dept, Taipei, Taiwan
[3] Koo Fdn Sun Yat Sen Canc Ctr, Dept Pathol, Taipei, Taiwan
[4] Koo Fdn Sun Yat Sen Canc Ctr, Dept Med Oncol, Taipei, Taiwan
[5] Koo Fdn Sun Yat Sen Canc Ctr, Dept Surg Oncol, Taipei, Taiwan
[6] Duke Univ, Inst Stat & Decis Sci, Durham, NC 27706 USA
[7] Duke Univ, Dept Radiat Oncol, Durham, NC 27706 USA
[8] Duke Univ, Dept Med, Durham, NC 27706 USA
[9] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27706 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 64卷 / 05期
关键词
breast cancer; mastectomy; radiotherapy; prediction model; prognostic score;
D O I
10.1016/j.ijrobp.2005.11.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To develop clinical prediction models for local regional recurrence (LRR) of breast carcinoma after mastectomy that will he superior to the conventional measures of tumor size and nodal status. Methods and Materials: Clinical information from 1,010 invasive breast cancer patients who had primary modified radical mastectomy formed the database of the training and testing of clinical prognostic and prediction models of LRR. Cox proportional hazards analysis and Bayesian tree analysis were the core methodologies from which these models were built. To generate a prognostic index model, 15 clinical variables were examined for their impact on LRR. Patients were stratified by lymph node involvement (< 4 vs. >= 4) and local regional status (recurrent vs. control) and then, within strata, randomly split into training and test data sets of equal size. To establish prediction tree models, 255 patients were selected by the criteria of having had LRR (53 patients) or no evidence of LRR without postmastectomy radiotherapy (PMRT) (202 patients). Results: With these models, patients can be divided into low-, intermediate-, and high-risk groups on the basis of axillary nodal status, estrogen receptor status, lymphovascular invasion, and age at diagnosis. In the low-risk group, there is no influence of PMRT on either LRR or survival. For intermediate-risk patients, PMRT improves LR control but not metastases-free or overall survival. For the high-risk patients, however, PMRT improves both LR control and metastasis-free and overall survival. Conclusion: The prognostic score and predictive index are useful methods to estimate the risk of LRR in breast cancer patients after mastectomy and for estimating the potential benefits of PMRT. These models provide additional information criteria for selection of patients for PMRT, compared with the traditional selection criteria of nodal status and tumor size. (c) 2006 Elsevier Inc.
引用
收藏
页码:1401 / 1409
页数:9
相关论文
共 27 条
[1]   Unique features of breast cancer in Taiwan [J].
Cheng, SH ;
Tsou, MH ;
Liu, MC ;
Jian, JJ ;
Cheng, JCH ;
Leu, SY ;
Hsieh, CY ;
Huang, AT .
BREAST CANCER RESEARCH AND TREATMENT, 2000, 63 (03) :213-223
[2]   The benefit and risk of postmastectomy radiation therapy in patients with high-risk breast cancer [J].
Cheng, SH ;
Jian, JJM ;
Chan, KY ;
Tsai, SYC ;
Liu, MC ;
Chen, CM .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (01) :12-17
[3]  
COX DR, 1972, J R STAT SOC B, V34, P187
[4]   CAUSE-SPECIFIC MORTALITY IN LONG-TERM SURVIVORS OF BREAST-CANCER WHO PARTICIPATED IN TRIALS OF RADIOTHERAPY [J].
CUZICK, J ;
STEWART, H ;
RUTQVIST, L ;
HOUGHTON, J ;
EDWARDS, R ;
REDMOND, C ;
PETO, R ;
BAUM, M ;
FISHER, B ;
HOST, H ;
LYTHGOE, J ;
RIBEIRO, G ;
SCHEURLEN, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) :447-453
[5]   Prognostic significance of local recurrence in breast cancer after postmastectomy radiotherapy [J].
Dunst, J ;
Steil, B ;
Furch, S ;
Fach, A ;
Lautenschläger, C ;
Diestelhorst, A ;
Lampe, D ;
Kölbl, H ;
Richter, C .
STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (10) :504-510
[6]   Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials [J].
Early Breast Cancer Trialists' Collaborative Group .
LANCET, 2000, 355 (9217) :1757-1770
[7]   IDENTIFICATION OF A SUBGROUP OF PATIENTS WITH BREAST-CANCER AND HISTOLOGICALLY POSITIVE AXILLARY NODES RECEIVING ADJUVANT CHEMOTHERAPY WHO MAY BENEFIT FROM POSTOPERATIVE RADIOTHERAPY [J].
FOWBLE, B ;
GRAY, R ;
GILCHRIST, K ;
GOODMAN, RL ;
TAYLOR, S ;
TORMEY, DC .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (07) :1107-1117
[8]   THE 5-YEAR RESULTS OF A RANDOMIZED TRIAL OF ADJUVANT RADIATION-THERAPY AFTER CHEMOTHERAPY IN BREAST-CANCER PATIENTS TREATED WITH MASTECTOMY [J].
GRIEM, KL ;
HENDERSON, IC ;
GELMAN, R ;
ASCOLI, D ;
SILVER, B ;
RECHT, A ;
GOODMAN, RL ;
HELLMAN, S ;
HARRIS, JR .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) :1546-1555
[9]   Gene expression predictors of breast cancer outcomes [J].
Huang, E ;
Cheng, SH ;
Dressman, H ;
Pittman, J ;
Tsou, MH ;
Horng, CF ;
Bild, A ;
Iversen, ES ;
Liao, M ;
Chen, CM ;
West, M ;
Nevins, JR ;
Huang, AT .
LANCET, 2003, 361 (9369) :1590-1596
[10]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481